XML 47 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 01, 2025
May 03, 2025
Nov. 02, 2024
May 04, 2024
Nov. 01, 2025
Nov. 02, 2024
Feb. 01, 2025
Cash flows from operating activities:              
Net loss $ (3,705) $ (11,824) $ (7,680) $ (8,830) $ (35,708) $ (31,014)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation of property and equipment         6,162 7,476  
Amortization of debt issuance and original issue discount costs         1,473 418  
Asset impairment 0   1   72 32  
Loss on sale of property and equipment         47 15  
Gain on sale of internally developed intangible assets (10,000)   0   (10,000) 0  
Stock-based compensation expense         323 809  
Loss on extinguishment of debt 0   3,338   0 3,338  
Changes in assets and liabilities:              
Inventories, net         (7,003) (37,129)  
Prepaid expenses and other current assets         (4,883) 713  
Accounts payable         11,185 15,209  
Accrued expenses and other liabilities         100 1,147  
Operating lease assets and liabilities         (2,504) 736  
Other assets and liabilities         4,747 (784)  
Net cash used in operating activities         (35,989) (39,034)  
Cash flows from investing activities:              
Proceeds from sale of property and equipment         24 20  
Proceeds from sale of internally developed intangible assets         10,000 0  
Capital expenditures         (1,927) (1,653)  
Net cash provided by (used in) investing activities         8,097 (1,633)  
Cash flows from financing activities:              
Borrowings on revolving line of credit         220,533 40,100  
Repayments on revolving line of credit         (201,931) (9,100)  
Borrowings on term loans         0 10,000  
Repayments on FILO term loan         0 (10,000)  
Prepayment penalties on extinguishment of debt         0 (2,638)  
Payments of debt and equity issuance costs         (1,018) (1,693)  
Cash used in net share settlement of stock options and restricted stock units         (55) (51)  
Proceeds from issuance of common stock         8,000 0  
Net cash provided by financing activities         30,529 43,618  
Cash and cash equivalents:              
Net increase         2,637 2,951  
Beginning of the period   3,820   $ 3,805 3,820 3,805 $ 3,805
End of the period $ 6,457   $ 6,756   6,457 6,756 $ 3,820
Supplemental schedule of non-cash activities:              
Non-cash accruals for purchases of property and equipment         465 516  
Non-cash accruals for debt and equity issuance costs         1,004 650  
Issuance of common stock to Bed Bath & Beyond, Inc. to convert term loan and accrued interest   $ 6,705          
Common stock issued in exchange for payment of equity issuance costs         574 0  
Conversion of Beyond Credit Agreement into Common Stock [Member]              
Supplemental schedule of non-cash activities:              
Issuance of common stock to Bed Bath & Beyond, Inc. to convert term loan and accrued interest         6,705 0  
Beyond [Member]              
Cash flows from financing activities:              
Proceeds from Beyond transaction         $ 5,000 $ 17,000